ID

16823

Description

Effect of TroVax in Patients Having Colorectal Cancer With Liver Metastases Removed; ODM derived from: https://clinicaltrials.gov/show/NCT00259844

Lien

https://clinicaltrials.gov/show/NCT00259844

Mots-clés

Versions (1)
  1. 09/08/2016 09/08/2016 -
Téléchargé le

9 août 2016

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Colorectal Neoplasms NCT00259844

Anglais

Eligibility Colorectal Neoplasms NCT00259844

1 Formulaires  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
colorectal adenocarcinoma with metastases confined only to the liver, histologically proven and considered suitable for treatment by surgical resection.
Description

Adenocarcinoma of large intestine | Secondary malignant neoplasm of liver | Indication Excision

Type de données

boolean

Alias
UMLS CUI [1]
C1319315
UMLS CUI [2]
C0494165
UMLS CUI [3,1]
C3146298
UMLS CUI [3,2]
C0728940
world health organisation (who) performance status of 0 or 1
Description

WHO performance status scale

Type de données

boolean

Alias
UMLS CUI [1]
C1298650
all toxic manifestations of previous treatment must have resolved. exceptions to this are alopecia or certain grade 1 toxicities which in the opinion of the investigator and cancer research uk should not exclude the patient.
Description

Prior Therapy Toxic effect Resolved | Alopecia Adverse Event | Standard toxicity grade 1

Type de données

boolean

Alias
UMLS CUI [1,1]
C1514463
UMLS CUI [1,2]
C0600688
UMLS CUI [1,3]
C3714811
UMLS CUI [2]
C1559115
UMLS CUI [3]
C1513302
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
radiotherapy, endocrine therapy, immunotherapy, systemic steroids, or chemotherapy during the previous four weeks (six weeks for nitrosoureas and mitomycin-c) prior to treatment or during the course of the trial.
Description

Therapeutic radiology procedure | Hormone Therapy | Immunotherapy | systemic steroids | Chemotherapy | Nitrosourea Compounds | Mitomycin

Type de données

boolean

Alias
UMLS CUI [1]
C1522449
UMLS CUI [2]
C0279025
UMLS CUI [3]
C0021083
UMLS CUI [4]
C2825233
UMLS CUI [5]
C0392920
UMLS CUI [6]
C0028210
UMLS CUI [7]
C0002475
patients who are high medical risks because of non-malignant systemic disease, including those with active uncontrolled infection.
Description

High risk Medical Due to Systemic disease Non-Malignant | Communicable Disease Uncontrolled

Type de données

boolean

Alias
UMLS CUI [1,1]
C0332167
UMLS CUI [1,2]
C0205476
UMLS CUI [1,3]
C0678226
UMLS CUI [1,4]
C0442893
UMLS CUI [1,5]
C1518371
UMLS CUI [2,1]
C0009450
UMLS CUI [2,2]
C0205318
concurrent serious infections within the 28 days prior to entry to the trial
Description

Communicable Diseases Serious

Type de données

boolean

Alias
UMLS CUI [1,1]
C0009450
UMLS CUI [1,2]
C0205404
current malignancies at other sites, with the exception of adequately treated cone-biopsied in situ carcinoma of the cervix uteri and basal or squamous cell carcinoma of the skin.
Description

Malignant Neoplasms Site | Carcinoma in situ of uterine cervix Conization Treated Adequate | Basal cell carcinoma | Squamous cell carcinoma of skin

Type de données

boolean

Alias
UMLS CUI [1,1]
C0006826
UMLS CUI [1,2]
C1515974
UMLS CUI [2,1]
C0851140
UMLS CUI [2,2]
C0195324
UMLS CUI [2,3]
C1522326
UMLS CUI [2,4]
C0205411
UMLS CUI [3]
C0007117
UMLS CUI [4]
C0553723
patients known to be serologically positive for hepatitis b, c or hiv
Description

Hepatitis B positive Serologic | Hepatitis C positive Serologic | HIV Seropositivity

Type de données

boolean

Alias
UMLS CUI [1,1]
C0856706
UMLS CUI [1,2]
C0205473
UMLS CUI [2,1]
C1112419
UMLS CUI [2,2]
C0205473
UMLS CUI [3]
C0019699
history of allergy to vaccinations or egg proteins.
Description

Hypersensitivity Vaccination | Hypersensitivity Egg Proteins

Type de données

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0042196
UMLS CUI [2,1]
C0020517
UMLS CUI [2,2]
C0013700
inflammatory bowel disease
Description

Inflammatory Bowel Disease

Type de données

boolean

Alias
UMLS CUI [1]
C0021390
history of autoimmune disease
Description

Autoimmune Disease

Type de données

boolean

Alias
UMLS CUI [1]
C0004364
clinical evidence of cerebral metastases
Description

Cerebral metastasis Evidence Clinical

Type de données

boolean

Alias
UMLS CUI [1,1]
C0555278
UMLS CUI [1,2]
C3887511
UMLS CUI [1,3]
C0205210
Retour au début de la page

Similar models

Eligibility Colorectal Neoplasms NCT00259844

1 Formulaires
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
Adenocarcinoma of large intestine | Secondary malignant neoplasm of liver | Indication Excision
Item
colorectal adenocarcinoma with metastases confined only to the liver, histologically proven and considered suitable for treatment by surgical resection.
boolean
C1319315 (UMLS CUI [1])
C0494165 (UMLS CUI [2])
C3146298 (UMLS CUI [3,1])
C0728940 (UMLS CUI [3,2])
WHO performance status scale
Item
world health organisation (who) performance status of 0 or 1
boolean
C1298650 (UMLS CUI [1])
Prior Therapy Toxic effect Resolved | Alopecia Adverse Event | Standard toxicity grade 1
Item
all toxic manifestations of previous treatment must have resolved. exceptions to this are alopecia or certain grade 1 toxicities which in the opinion of the investigator and cancer research uk should not exclude the patient.
boolean
C1514463 (UMLS CUI [1,1])
C0600688 (UMLS CUI [1,2])
C3714811 (UMLS CUI [1,3])
C1559115 (UMLS CUI [2])
C1513302 (UMLS CUI [3])
Item Group
C0680251 (UMLS CUI)
Therapeutic radiology procedure | Hormone Therapy | Immunotherapy | systemic steroids | Chemotherapy | Nitrosourea Compounds | Mitomycin
Item
radiotherapy, endocrine therapy, immunotherapy, systemic steroids, or chemotherapy during the previous four weeks (six weeks for nitrosoureas and mitomycin-c) prior to treatment or during the course of the trial.
boolean
C1522449 (UMLS CUI [1])
C0279025 (UMLS CUI [2])
C0021083 (UMLS CUI [3])
C2825233 (UMLS CUI [4])
C0392920 (UMLS CUI [5])
C0028210 (UMLS CUI [6])
C0002475 (UMLS CUI [7])
High risk Medical Due to Systemic disease Non-Malignant | Communicable Disease Uncontrolled
Item
patients who are high medical risks because of non-malignant systemic disease, including those with active uncontrolled infection.
boolean
C0332167 (UMLS CUI [1,1])
C0205476 (UMLS CUI [1,2])
C0678226 (UMLS CUI [1,3])
C0442893 (UMLS CUI [1,4])
C1518371 (UMLS CUI [1,5])
C0009450 (UMLS CUI [2,1])
C0205318 (UMLS CUI [2,2])
Communicable Diseases Serious
Item
concurrent serious infections within the 28 days prior to entry to the trial
boolean
C0009450 (UMLS CUI [1,1])
C0205404 (UMLS CUI [1,2])
Malignant Neoplasms Site | Carcinoma in situ of uterine cervix Conization Treated Adequate | Basal cell carcinoma | Squamous cell carcinoma of skin
Item
current malignancies at other sites, with the exception of adequately treated cone-biopsied in situ carcinoma of the cervix uteri and basal or squamous cell carcinoma of the skin.
boolean
C0006826 (UMLS CUI [1,1])
C1515974 (UMLS CUI [1,2])
C0851140 (UMLS CUI [2,1])
C0195324 (UMLS CUI [2,2])
C1522326 (UMLS CUI [2,3])
C0205411 (UMLS CUI [2,4])
C0007117 (UMLS CUI [3])
C0553723 (UMLS CUI [4])
Hepatitis B positive Serologic | Hepatitis C positive Serologic | HIV Seropositivity
Item
patients known to be serologically positive for hepatitis b, c or hiv
boolean
C0856706 (UMLS CUI [1,1])
C0205473 (UMLS CUI [1,2])
C1112419 (UMLS CUI [2,1])
C0205473 (UMLS CUI [2,2])
C0019699 (UMLS CUI [3])
Hypersensitivity Vaccination | Hypersensitivity Egg Proteins
Item
history of allergy to vaccinations or egg proteins.
boolean
C0020517 (UMLS CUI [1,1])
C0042196 (UMLS CUI [1,2])
C0020517 (UMLS CUI [2,1])
C0013700 (UMLS CUI [2,2])
Inflammatory Bowel Disease
Item
inflammatory bowel disease
boolean
C0021390 (UMLS CUI [1])
Autoimmune Disease
Item
history of autoimmune disease
boolean
C0004364 (UMLS CUI [1])
Cerebral metastasis Evidence Clinical
Item
clinical evidence of cerebral metastases
boolean
C0555278 (UMLS CUI [1,1])
C3887511 (UMLS CUI [1,2])
C0205210 (UMLS CUI [1,3])
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial